Do you like it here? bimatoprost pharmacology (http://www.poly.ee/polygon/#elf) That accounts for a market value of just over $8 billion,based on current trading, compared with the target valuationimplied by the share sale, according to a banking source, ofbetween $10 billion and $11 billion.